Display options
Share it on

Cell Mol Life Sci. 2012 Dec;69(24):4239-55. doi: 10.1007/s00018-012-1111-5.

Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors.

Cellular and molecular life sciences : CMLS

John C Deacon, Marieke J Bloemink, Heresh Rezavandi, Michael A Geeves, Leslie A Leinwand

Affiliations

  1. Department of Molecular, Cellular and Developmental Biology and Biofrontiers Institute, University of Colorado, MCDB, UCB 347, Boulder, CO 80309, USA.

PMID: 23001010 PMCID: PMC3685716 DOI: 10.1007/s00018-012-1111-5

Abstract

The myosin isoform composition of the heart is dynamic in health and disease and has been shown to affect contractile velocity and force generation. While different mammalian species express different proportions of α and β myosin heavy chain, healthy human heart ventricles express these isoforms in a ratio of about 1:9 (α:β) while failing human ventricles express no detectable α-myosin. We report here fast-kinetic analysis of recombinant human α and β myosin heavy chain motor domains. This represents the first such analysis of any human muscle myosin motor and the first of α-myosin from any species. Our findings reveal substantial isoform differences in individual kinetic parameters, overall contractile character, and predicted cycle times. For these parameters, α-subfragment 1 (S1) is far more similar to adult fast skeletal muscle myosin isoforms than to the slow β isoform despite 91% sequence identity between the motor domains of α- and β-myosin. Among the features that differentiate α- from β-S1: the ATP hydrolysis step of α-S1 is ~ten-fold faster than β-S1, α-S1 exhibits ~five-fold weaker actin affinity than β-S1, and actin·α-S1 exhibits rapid ADP release, which is >ten-fold faster than ADP release for β-S1. Overall, the cycle times are ten-fold faster for α-S1 but the portion of time each myosin spends tightly bound to actin (the duty ratio) is similar. Sequence analysis points to regions that might underlie the basis for this finding.

References

  1. J Biol Chem. 2003 May 9;278(19):17466-74 - PubMed
  2. Biochemistry. 1978 Dec 12;17(25):5423-30 - PubMed
  3. Biochemistry. 1997 Jan 14;36(2):317-23 - PubMed
  4. Circ Res. 1995 Aug;77(2):439-44 - PubMed
  5. J Mol Cell Cardiol. 2003 Jan;35(1):91-7 - PubMed
  6. J Biol Chem. 2007 Feb 9;282(6):3559-70 - PubMed
  7. J Physiol. 1999 Sep 15;519 Pt 3:669-78 - PubMed
  8. Am J Physiol. 1995 Sep;269(3 Pt 1):C785-90 - PubMed
  9. J Mol Biol. 2007 Nov 9;373(5):1184-97 - PubMed
  10. Annu Rev Biochem. 1999;68:687-728 - PubMed
  11. J Biol Chem. 1971 Aug 10;246(15):4866-71 - PubMed
  12. Annu Rev Cell Dev Biol. 1996;12:417-39 - PubMed
  13. Biochem J. 1985 Dec 1;232(2):343-9 - PubMed
  14. J Biol Chem. 1998 Mar 13;273(11):6262-70 - PubMed
  15. Biochem J. 1976 Nov;159(2):301-15 - PubMed
  16. Neuromuscul Disord. 2007 May;17(5):355-67 - PubMed
  17. J Muscle Res Cell Motil. 1994 Feb;15(1):11-9 - PubMed
  18. Nature. 1994 Apr 7;368(6471):567-9 - PubMed
  19. J Mol Biol. 2006 Jan 20;355(3):432-42 - PubMed
  20. J Mol Cell Cardiol. 2010 May;48(5):999-1006 - PubMed
  21. J Clin Invest. 1997 Nov 1;100(9):2362-70 - PubMed
  22. J Gen Physiol. 1967 Jul;50(6):Suppl:197-218 - PubMed
  23. J Mol Biol. 2007 May 11;368(4):1051-66 - PubMed
  24. Biochem J. 1973 Jan;131(1):127-37 - PubMed
  25. Circ Res. 2000 Mar 3;86(4):386-90 - PubMed
  26. Biochemistry. 1978 Aug 22;17(17):3432-42 - PubMed
  27. Philos Trans R Soc Lond B Biol Sci. 2004 Dec 29;359(1452):1867-77 - PubMed
  28. Nature. 1994 Dec 8;372(6506):515-8 - PubMed
  29. Circ Res. 2007 Apr 27;100(8):1182-90 - PubMed
  30. J Cell Sci. 2003 Oct 15;116(Pt 20):4227-38 - PubMed
  31. N Engl J Med. 2002 May 2;346(18):1357-65 - PubMed
  32. J Biol Chem. 1999 Sep 17;274(38):27265-73 - PubMed
  33. Circulation. 2005 May 10;111(18):2339-46 - PubMed
  34. J Mol Biol. 1999 Jul 2;290(1):61-75 - PubMed
  35. Pflugers Arch. 2007 Apr;454(1):63-73 - PubMed
  36. J Biol Chem. 1984 Apr 25;259(8):5045-53 - PubMed
  37. J Biol Chem. 2008 Jul 18;283(29):20579-89 - PubMed
  38. J Cell Biol. 1979 Apr;81(1):10-25 - PubMed
  39. Proc Natl Acad Sci U S A. 1985 Feb;82(3):658-62 - PubMed
  40. J Exp Biol. 2005 Nov;208(Pt 22):4243-53 - PubMed
  41. Nature. 1999 Apr 8;398(6727):530-3 - PubMed
  42. Ann Biomed Eng. 2008 Oct;36(10):1624-40 - PubMed
  43. Nature. 1975 Sep 4;257(5521):54-6 - PubMed
  44. Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1446-54 - PubMed
  45. Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1053-8 - PubMed
  46. Circ Res. 2002 Jun 14;90(11):1150-2 - PubMed
  47. FASEB J. 2010 Feb;24(2):415-24 - PubMed
  48. Biochem J. 1988 Feb 1;249(3):735-43 - PubMed
  49. Methods Enzymol. 1982;85 Pt B:55-71 - PubMed
  50. Science. 2008 Jul 4;321(5885):133-6 - PubMed
  51. Biochemistry. 2004 Nov 30;43(47):15058-65 - PubMed
  52. Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):87-92 - PubMed
  53. J Muscle Res Cell Motil. 1996 Dec;17(6):669-76 - PubMed
  54. J Biol Chem. 1995 Dec 22;270(51):30260-3 - PubMed
  55. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8619-23 - PubMed
  56. J Appl Physiol (1985). 2001 May;90(5):1927-35 - PubMed
  57. J Mol Cell Cardiol. 2006 Sep;41(3):467-77 - PubMed
  58. Biochemistry. 1998 May 5;37(18):6317-26 - PubMed

Substances

MeSH terms

Publication Types

Grant support